A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)

Clinical trial NCT01165320 · COMPLETED

Trial details

NCT number: NCT01165320
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Candidiasis, Esophageal Candidiasis, Invasive Aspergillosis

Start date: 2010-07-06
Primary completion: 2013-09-17
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.